Paul Rivard
2021
In 2021, Paul Rivard earned a total compensation of $1.8M as Executive Vice President of Operations and General Counsel at Akers Biosciences, a 953% increase compared to previous year.
Compensation breakdown
| Bonus | $60,000 |
|---|---|
| Salary | $165,000 |
| Stock Awards | $1,618,000 |
| Total | $1,843,000 |
Rivard received $1.6M in stock awards, accounting for 88% of the total pay in 2021.
Rivard also received $60K in bonus and $165K in salary.
Rankings
In 2021, Paul Rivard's compensation ranked 6,365th out of 12,415 executives tracked by ExecPay. In other words, Rivard earned more than 48.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,365 out of 12,415 | 49th |
Division Manufacturing | 2,714 out of 5,505 | 51st |
Major group Chemicals And Allied Products | 1,194 out of 2,375 | 50th |
Industry group Drugs | 1,062 out of 2,096 | 49th |
Industry In Vitro and In Vivo Diagnostic Substances | 24 out of 61 | 61st |
Source: SEC filing on October 26, 2022.
Rivard's colleagues
We found three more compensation records of executives who worked with Paul Rivard at Akers Biosciences in 2021.
News
Akers Biosciences Chief Medical Officer Christopher Chapman's 2023 pay jumps 1,002% to $2.9M
November 1, 2024
Akers Biosciences CSO Adam Kaplin's 2022 pay falls 93% to $354K
June 30, 2023
Akers Biosciences CSO Adam Kaplin's 2021 pay jumps 1,350% to $5.2M
October 26, 2022
Akers Biosciences CEO Christopher Schreiber's 2020 pay jumps 1,909% to $1.1M
November 22, 2021